Familiarity, confidence and preference of artificial intelligence feedback and prompts by Australian breast cancer screening readers.

Journal: Australian health review : a publication of the Australian Hospital Association
Published Date:

Abstract

Objectives This study explored the familiarity, perceptions and confidence of Australian radiology clinicians involved in reading screening mammograms, regarding artificial intelligence (AI) applications in breast cancer detection. Methods Sixty-five radiologists, breast physicians and radiology trainees participated in an online survey that consisted of 23 multiple choice questions asking about their experience and familiarity with AI products. Furthermore, the survey asked about their confidence in using AI outputs and their preference for AI modes applied in a breast screening context. Participants' responses to questions were compared using Pearson's χ 2 test. Bonferroni-adjusted significance tests were used for pairwise comparisons. Results Fifty-five percent of respondents had experience with AI in their workplaces, with automatic density measurement powered by machine learning being the most familiar AI product (69.4%). The top AI outputs with the highest ranks of perceived confidence were 'Displaying suspicious areas on mammograms with the percentage of cancer possibility' (67.8%) and 'Automatic mammogram classification (normal, benign, cancer, uncertain)' (64.6%). Radiology and breast physicians preferred using AI as second-reader mode (75.4% saying 'somewhat happy' to 'extremely happy') over triage (47.7%), pre-screening and first-reader modes (both with 26.2%) (P  < 0.001). Conclusion The majority of screen readers expressed increased confidence in utilising AI for highlighting suspicious areas on mammograms and for automatically classifying mammograms. They considered AI as an optimal second-reader mode being the most ideal use in a screening program. The findings provide valuable insights into the familiarities and expectations of radiologists and breast clinicians for the AI products that can enhance the effectiveness of the breast cancer screening programs, benefitting both healthcare professionals and patients alike.

Authors

  • Phuong Dung Yun Trieu
    Discipline of Medical Imaging Sciences, School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Melissa L Barron
    Discipline of Medical Imaging Sciences, School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Zhengqiang Jiang
    Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China. Electronic address: zhqjiang@cau.edu.cn.
  • Seyedamir Tavakoli Taba
    Discipline of Medical Imaging Sciences, Faculty of Medicine and Health, University of Sydney, D18- Level 7 - Susan Wakil Health Building, Camperdown, NSW 2006, Australia.
  • Ziba Gandomkar
    Image Optimisation and Perception, Discipline of Medical Imaging and Radiation Sciences, Faculty of Health Sciences, University of Sydney, Sydney, NSW, Australia. Electronic address: ziba.gandomkar@sydney.edu.au.
  • Sarah J Lewis
    Discipline of Medical Imaging Science, The University of Sydney, Lidcombe, New South Wales, Australia.